3 recruiting, 2 completed, 2 not yet recruiting, 1 enrolling by invitation. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Hepatecellular Carcinoma: new trials by email Literature Review of Hepatecellular Carcinoma trials Research Report on Hepatecellular Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors SHY-ONC6 - Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC) | Phase 1 | Recruiting | SHY Therapeutics | 30 | 2026-06-24 | 2026-10-22 |
| Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study Hepatecellular Carcinoma | Not yet recruiting | Xiangya Hospital of Central South University | 32 | 2026-03-02 | 2026-03-19 | |
| Affordable Made-in-India Microspheres for Liver Cancer Therapy 90Y-Theraspheres, 188Re-Microspheres - Hepatecellular Carcinoma | Phase 1 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 18 | 2026-02-15 | 2026-03-12 |
| QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT Iparomlimab and Tuvonralimab Injection (QL1706), Bevacizumab, Hepatic Arterial Infusion Chemotherapy with Raltitrexed and Oxaliplatin (RALOX-HAIC) - Hepatecellular Carcinoma, RALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin | Phase 2 | Recruiting | Nanfang Hospital, Southern Medical University | 38 | 2025-12-25 | 2026-01-13 |
| AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR) Curative liver resection, Real-world multimodal therapy - Hepatecellular Carcinoma, Hepatectomy | Recruiting | Tongji Hospital | 353 | 2025-06-10 | 2025-09-03 | |
| STOP HCC-GAAD-APAC-Thailand GAAD score - Hepatecellular Carcinoma, Cirrhosis | Not applicable | Enrolling by invitation | Mahidol University | 2100 | 2025-02-02 | 2026-01-06 |
| HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival Hepatecellular Carcinoma, Liver Injury | Completed | Nanfang Hospital, Southern Medical University | 562 | 2023-10-01 | 2025-12-11 | |
| Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma Hepatectomy - Hepatectomy, Hepatecellular Carcinoma | Completed | University of Milan | 336 | 2004-01-01 | 2014-06-18 |
Fibrosis (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Liver Neoplasms (1) · Mesothelioma (1) · Sarcoma (1) · Stomach Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma (1) · Adenoma (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1)
Bevacizumab (1) · Hepatectomy (1) · Oxaliplatin (1) · raltitrexed (1)
Nanfang Hospital, Southern Medical University (2) · Mahidol University (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · SHY Therapeutics (1) · Tongji Hospital (1) · University of Milan (1) · Xiangya Hospital of Central South University (1)
China (3) · India (1) · Italy (1) · Thailand (1) · United States (1)
Jaya Shukla, Ph.D. Nuclear Medicine (1) · Jinzhang Chen (1) · Jinzhang Chen, Study Director (1) · Tawesak Tanwandee (1) · Tawesak Tanwandee, MD (1)
PMID 25217112, PMID 28620797, PMID 29425931, PMID 29628281, PMID 31712073, PMID 37199193